Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CANARX is a healthcare services company that specializes in managing international prescription drug programs for public and private sector employers. The company facilitates access to brand-name maintenance medications from licensed pharmacies in Tier-1 countries, such as Canada, the United Kingdom, and Australia, at significantly reduced costs. By bypassing traditional domestic supply chains, CANARX helps self-insured entities reduce their pharmacy benefit expenditures while providing zero-dollar copays to members. Their service model focuses on safety and compliance, utilizing a network of government-regulated pharmacies to dispense medications directly to patients. The company operates as a facilitator rather than a pharmacy, ensuring that all prescriptions are reviewed by licensed pharmacists in the country of origin. This approach allows organizations to offer an additional, voluntary pharmacy benefit that addresses the rising cost of specialty and maintenance drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CANARX.